Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology.
about
Cardiac asthma in elderly patients: incidence, clinical presentation and outcomeNatriuretic peptides for acute heart failureNon-invasive positive pressure ventilation (CPAP or bilevel NPPV) for cardiogenic pulmonary oedemaNon-invasive positive pressure ventilation (CPAP or bilevel NPPV) for cardiogenic pulmonary edemaNatriuretic peptides for acute heart failureAgents with inotropic properties for the management of acute heart failure syndromes. Traditional agents and beyondLevosimendan vs. dobutamine: outcomes for acute heart failure patients on beta-blockers in SURVIVEAcute decompensated heart failure: contemporary medical managementTreating critical illness: the importance of first doing no harmCardiopulmonary laboratory biomarkers in the evaluation of acute dyspneaConsiderations for initial therapy in the treatment of acute heart failureHeart failure and Alzheimer's diseaseHeart failure in the Middle EastAnesthetic Challenges in Robotic-assisted Urologic Surgery.Mechanistic insight into the functional and toxic effects of Strophanthidin in the failing human myocardiumRelation of tricuspid annular displacement and tissue Doppler imaging velocities with duration of weaning in mechanically ventilated patients with acute pulmonary edemaBarriers to accurate diagnosis and effective management of heart failure have not changed in the past 10 years: a qualitative study and national survey.Microcirculatory assessment of patients under VA-ECMO.Acidemia does not affect outcomes of patients with acute cardiogenic pulmonary edema treated with continuous positive airway pressure.Outcomes of patients hospitalized for acute decompensated heart failure: does nesiritide make a difference?Boussignac continuous positive airway pressure for the management of acute cardiogenic pulmonary edema: prospective study with a retrospective control group.Role of beta-blockers in patients admitted for worsening heart failure in a real world setting: data from the Italian Survey on Acute Heart Failure.Continuous administration of recombinant human B-type natriuretic peptide can improve heart and renal function in patients after cardiopulmonary bypass surgery.A pilot study of target weight guided treatment in acute heart failure using ultrafiltration or usual care: effect on sodium removal.Multidimensional Prognostic Index based on a comprehensive geriatric assessment predicts short-term mortality in older patients with heart failure.The basic social medical insurance is associated with clinical outcomes in the patients with ST-elevation myocardial infarction: a retrospective study from Shanghai, ChinaThe influence of heart failure self-care on health outcomes: hypothetical cardioprotective mechanisms.Clinical review: practical recommendations on the management of perioperative heart failure in cardiac surgery.Beneficial effects of testosterone therapy on functional capacity, cardiovascular parameters, and quality of life in patients with congestive heart failure.Tolvaptan: the evidence for its therapeutic value in acute heart failure syndromeDEFEAT - Heart Failure: a guide to management of geriatric heart failure by generalist physicians.A retrospective characterization of worsening renal function in patients with acute decompensated heart failure receiving nesiritide.Combination of uric acid and NT-ProBNP: a more useful prognostic marker for short-term clinical outcomes in patients with acute heart failureUsing the method of judgement analysis to address variations in diagnostic decision makingAcute pulmonary oedema in pregnant women.Acute and acute-on-chronic kidney injury of patients with decompensated heart failure: impact on outcomes.Prognostic significance of a multimarker strategy of biomarkers in acute heart failure.Clinical profile, contemporary management and one-year mortality in patients with severe acute heart failure syndromes: The EFICA study.The role of plasma biomarkers in acute heart failure. Serial changes and independent prognostic value of NT-proBNP and cardiac troponin-T.Current treatment options for early management in acute decompensated heart failure.
P2860
Q21261942-3C564017-18AB-448E-ADF1-CD6A38914096Q24194433-11B2CD92-80F6-42C7-9B8F-C19FD7F1961CQ24202909-B73C78DB-B728-455A-A2DE-381D8D417E73Q24242752-D2C28DDC-51EA-470A-B87C-C1DF50DBD9B2Q24245105-17028DAE-DBB4-40C4-93E4-1E9689A0995AQ24645066-AC5C43DB-EFEF-407B-BE79-C2300D0C4889Q24650903-BB85EFD8-5945-425F-A0C1-CA812C77FE67Q24650932-6344632B-D3D3-494F-AFF1-905B5C5F069EQ24813804-185F605D-FF2F-4E41-A1DD-52C433FEED2AQ26745756-5437CFF8-5D5A-4667-9C7B-79347532862EQ26778120-49B4ABD1-8C83-4FC4-B116-5964BA0BF762Q26852526-484F7042-9C9B-409A-A27C-4C2F49F8DC47Q26865181-65F0B01E-5581-4F15-B9AF-CEE2D028B1CFQ27687088-C199FCBF-C817-4251-91E3-A1FE49241D14Q28254443-E3500214-0720-47C6-B885-B626FFA3ADDFQ30481142-D83342E3-C69C-41D2-83D1-57579E8D0AA2Q30575444-FD6107D0-58A8-47DF-BAAA-864BCDC277B5Q30826381-03AA5020-C7DB-41B8-B92E-73A8ED12CD5CQ33159403-39B3C8E5-F561-4109-B77B-AA87C55920B4Q33307212-9F9777BD-20DE-4A70-9B84-02B2868AE610Q33311587-C4586F7A-30DF-4485-92E8-CBAE5EA9471EQ33400219-E920B4E4-AA30-4131-A5A0-020EC3235EACQ33571255-5632B919-9180-4216-BE33-3BA10DFB98AEQ33681956-44C8D302-3A65-4D09-8B79-049395FC0D31Q33825320-F08F0CF8-E750-4A0B-A2C9-30F40FFF6F32Q33843868-A8CBB1B2-816E-4D2D-8533-6BDA13C2C9E3Q33897455-1C517865-F88A-4C7A-8E1D-73BBE1AD2FBDQ33918932-3B2C2EA3-1FD9-47CF-B3BB-F14C1644A31BQ33943721-F2C7E74B-0048-44D8-911E-D4C2C967231FQ33973976-BCEB7355-C0A9-46EE-83CA-B4DB1DA9208CQ34038879-9050C4A6-F6AD-4C9C-8396-053AD9F0ABC4Q34069726-B03A3FD3-37F0-4E69-9CFD-0CDEFF52FAD9Q34102097-21EE92B1-AB5C-47E2-9F53-54D3632FDE62Q34194293-4D901366-C1A4-4B67-9B38-E577BF77A52EQ34196971-799DA2EA-01DB-41C4-AAD4-16CE852C03C9Q34322180-A52C6619-3191-4F39-9CDD-DD5CF3EECB09Q34479808-504FCEE1-7322-48C0-8B9B-067D8814C410Q34565386-14510A4E-42CF-429F-AE7A-26CBFA9073BDQ34580385-595C9A90-6F1E-41F2-B68E-C7048229AFC6Q34796529-1E2422FF-C71D-41AC-9873-80C52E346C02
P2860
Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Executive summary of the guide ...... uropean Society of Cardiology.
@ast
Executive summary of the guide ...... uropean Society of Cardiology.
@en
Executive summary of the guide ...... uropean Society of Cardiology.
@nl
type
label
Executive summary of the guide ...... uropean Society of Cardiology.
@ast
Executive summary of the guide ...... uropean Society of Cardiology.
@en
Executive summary of the guide ...... uropean Society of Cardiology.
@nl
prefLabel
Executive summary of the guide ...... uropean Society of Cardiology.
@ast
Executive summary of the guide ...... uropean Society of Cardiology.
@en
Executive summary of the guide ...... uropean Society of Cardiology.
@nl
P2093
P50
P356
P1476
Executive summary of the guide ...... uropean Society of Cardiology.
@en
P2093
Andrew Rhodes
Andrzej Budaj
Anibal Albuquerque
Antonello Gavazzi
Bertil Lindahl
ESC Committe for Practice Guideline (CPG)
Enrique Fernandez Burgos
Ferenc Follath
Gerasimos S Filippatos
P304
P356
10.1093/EURHEARTJ/EHI044
P50
P577
2005-01-28T00:00:00Z